Please ensure Javascript is enabled for purposes of website accessibility

2 Top Value Stocks to Buy Right Now

By Will Ebiefung - Mar 14, 2021 at 8:15AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These companies trade at attractive valuations compared to their long-term potential.

Smart shoppers want to get more for less, and the same is true for investors looking for their next portfolio addition. Let's explore the reasons why Walmart (WMT 2.13%) and Johnson & Johnson (JNJ -0.09%) offer some of the best bargains for your investing buck in the stock market right now. 

1. Walmart 

With a forward price-to-earnings (P/E) ratio of 24, Walmart isn't the quintessential example of a value stock. But it is significantly cheaper than the S&P 500 average P/E of 39, and shares look downright affordable considering its potential to become a market leader in e-commerce.

E-commerce is the future of retail, and the coronavirus pandemic accelerated this transition. Digital penetration in retail hit 21% in 2020, up from just 16% in 2019, and Walmart's future will depend on how well it can adapt to this evolving industry. So far, the company is doing a bang-up job -- launching its membership platform, Walmart+, in September. 

A large stock chart with a blue arrow going up.

Image source: Getty Images.

Charging subscribers $98 per year, Walmart has positioned itself as an affordable alternative to Amazon's Prime membership, which costs $119 per year. And while Walmart+ doesn't currently offer nifty perks like movie or music streaming, its network of over 4,700 locations lets it match or potentially exceed Amazon Prime in last-mile delivery (Amazon's Whole Foods subsidiary only has 500 locations).

According to CEO Doug McMillon, Walmart plans to add more benefits to Walmart+ to "broaden its appeal," but he has been tight-lipped about the details so far. 

Walmart's fourth-quarter revenue grew 7.3% to $152 billion, while adjusted earnings per share (EPS) rose 0.7% to $1.39. The company also returns value to investors through a 1.7% dividend that it has increased for 48 consecutive years, earning Dividend Aristocrat status

2. Johnson & Johnson 

Johnson & Johnson is a value stock that can hold its own in any economic environment. The mega-cap healthcare and consumer goods giant sports a forward price-to-earnings multiple of just 17. And it sells products that maintain demand during recessions (and pandemics), such as over-the-counter medications, baby care, and pharmaceuticals. Its new COVID-19 vaccine could also help boost growth over the long term. 

Johnson & Johnson's vaccine received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration in February. The company plans to ship 100 million doses in the U.S. by the end of June and an additional 100 million doses by the end of the year. 

A rolled-up dollar bill wrapped in a bandage alongside some pill bottles.

Image source: Getty Images.

The vaccine has been determined to be 72% effective at preventing moderate to severe disease in the U.S. -- compared to the double-dose vaccines of Moderna and Pfizer, which boast efficacy rates of 94% and 95%, respectively. All three vaccines are considered to be nearly 100% effective at preventing death from the coronavirus. But Johnson & Johnson's vaccine has an advantage in logistics because it only needs one dose to work and requires a less elaborate cold-storage chain. The company isn't producing the vaccine for profit during the pandemic but could increase prices after the immediate crisis ends. 

Fourth-quarter sales increased 8.3% to $22.5 billion as strong pharmaceutical sales helped offset weakness in the medical devices segment. Like Walmart, the company is a Dividend Aristocrat with 58 consecutive years of payout growth. The stock currently yields 2.6%.

Bang for your buck 

With the S&P 500 trading at an unusually high P/E ratio of 39 (compared to its historical average of 16), now is the time to bet on value stocks. Walmart and Johnson & Johnson are poised for long-term success because of their crisis-proof business models and ability to quickly pivot to new opportunities such as e-commerce and vaccines. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$179.46 (-0.09%) $0.16
Wal-Mart Stores, Inc. Stock Quote
Wal-Mart Stores, Inc.
WMT
$126.00 (2.13%) $2.63

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
332%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.